Retour
Fourchette du Jour
201,80 €
206,01 €
Fourchette 52 Semaines
164,39 €
244,81 €
Volume
6 972 423
Moyenne 50J / 200J
223,12 €
/
215,25 €
Clôture Précédente
204,93 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 85,8 | 0,3 |
| P/B | — | 2,9 |
| ROE % | 15367,3 | 3,7 |
| Net Margin % | 6,9 | 3,8 |
| Rev Growth 5Y % | 2,1 | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Hold
256,15 €
+24.9%
Low: 223,00 €
High: 299,00 €
P/E Prévisionnel
14,1
BPA Prévisionnel
14,57 €
Croissance BPA (est.)
+0,0%
CA Est.
67 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
20,05 €
19,56 € – 20,40 €
|
84 B | 5 |
| FY2029 |
19,55 €
19,07 € – 19,89 €
|
82 B | 10 |
| FY2028 |
17,87 €
13,13 € – 21,13 €
|
78 B | 12 |
Insider Trading Activity
20 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 |
Michael Robert A.
CHAIRMAN OF THE BOARD AND CEO
|
other | 36 523 | 232,08 € | 8 476 258 € |
| Feb 27, 2026 |
Reents Scott T
EVP, CHIEF FINANCIAL OFFICER
|
other | 21 638 | 232,08 € | 5 021 747 € |
| Feb 27, 2026 |
Donoghoe Nicholas
EVP, CHIEF BUS/STRAT OFFICER
|
other | 12 874 | 232,08 € | 2 987 798 € |
| Feb 27, 2026 |
Purdue David Ryan
SVP, Controller
|
other | 2 692 | 232,08 € | 624 759 € |
| Feb 27, 2026 |
Thakkar Roopal
EVP, R&D and CSO
|
other | 8 037 | 232,08 € | 1 865 227 € |
| Feb 27, 2026 |
SALEKI-GERHARDT AZITA
EVP, CHIEF OPERATIONS OFFICER
|
other | 16 309 | 232,08 € | 3 784 993 € |
| Dec 31, 2025 |
Quaggin Susan E
|
grant | 68 | 228,49 € | 15 537 € |
| Sep 30, 2025 |
RAPP EDWARD J
|
grant | 145 | 231,54 € | 33 573 € |
| Sep 30, 2025 |
Quaggin Susan E
|
grant | 67 | 231,54 € | 15 513 € |
| Jun 30, 2025 |
Quaggin Susan E
|
grant | 81 | 185,62 € | 15 035 € |
| Jun 30, 2025 |
Alpern Robert J
|
grant | 40 | 185,62 € | 7 425 € |
| May 9, 2025 |
Davis Jennifer L.
|
grant | 1 203 | — | — |
| May 9, 2025 |
Alpern Robert J
|
grant | 1 203 | — | — |
| May 9, 2025 |
Quaggin Susan E
|
grant | 1 203 | — | — |
| May 9, 2025 |
Hart Brett J
|
grant | 1 203 | — | — |
| May 9, 2025 |
AUSTIN ROXANNE S
|
grant | 1 203 | — | — |
| May 9, 2025 |
RAPP EDWARD J
|
grant | 1 203 | — | — |
| May 9, 2025 |
WADDELL FREDERICK H
|
grant | 1 203 | — | — |
| Mar 31, 2025 |
GONZALEZ RICHARD A
|
other | 2 450 | — | — |
| Mar 31, 2025 |
RAPP EDWARD J
|
grant | 155 | 209,52 € | 32 476 € |
Points Clés
Revenue grew 2,14% annually over 5 years — modest growth
ROE of 15367,27% indicates high profitability
Generating 17,82B in free cash flow
P/E of 85,82 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6,43%
Cash machine — converts 421,58% of earnings into free cash flow
Croissance
Revenue Growth (5Y)
2,14%
Revenue (1Y)8,57%
Earnings (1Y)-1,22%
FCF Growth (3Y)-10,14%
Qualité
Return on Equity
15367,27%
ROIC24,18%
Net Margin6,91%
Op. Margin34,69%
Sécurité
Debt / Equity
N/A
Current Ratio0,67
Interest Coverage8,08
Valorisation
P/E Ratio
85,82
P/B RatioN/A
EV/EBITDA20,11
Dividend Yield0,03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,57% | Revenue Growth (3Y) | 6,11% |
| Earnings Growth (1Y) | -1,22% | Earnings Growth (3Y) | -6,78% |
| Revenue Growth (5Y) | 2,14% | Earnings Growth (5Y) | -22,21% |
| Profitability | |||
| Revenue (TTM) | 61,16B | Net Income (TTM) | 4,23B |
| ROE | 15367,27% | ROA | 3,15% |
| Gross Margin | 83,71% | Operating Margin | 34,69% |
| Net Margin | 6,91% | Free Cash Flow (TTM) | 17,82B |
| ROIC | 24,18% | FCF Growth (3Y) | -10,14% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,67 |
| Interest Coverage | 8,08 | Dividend Yield | 0,03% |
| Valuation | |||
| P/E Ratio | 85,82 | P/B Ratio | N/A |
| P/S Ratio | 5,93 | PEG Ratio | -116,18 |
| EV/EBITDA | 20,11 | Dividend Yield | 0,03% |
| Market Cap | 362,69B | Enterprise Value | 426,53B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 61,16B | 56,33B | 54,32B | 58,05B | 56,20B |
| Net Income | 4,23B | 4,28B | 4,86B | 11,84B | 11,54B |
| EPS (Diluted) | 2,36 | 2,39 | 2,72 | 6,63 | 6,45 |
| Gross Profit | 51,20B | 39,43B | 33,90B | 40,64B | 38,75B |
| Operating Income | 21,21B | 9,14B | 12,76B | 18,12B | 17,92B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 133,96B | 135,16B | 134,71B | 138,81B | 146,53B |
| Total Liabilities | 137,19B | 131,80B | 124,31B | 121,52B | 131,09B |
| Shareholders' Equity | -3,27B | 3,33B | 10,36B | 17,25B | 15,41B |
| Total Debt | 69,07B | 67,84B | 60,12B | 64,19B | 77,58B |
| Cash & Equivalents | 5,23B | 5,52B | 12,81B | 9,20B | 9,75B |
| Current Assets | 29,06B | 25,58B | 33,00B | 28,46B | 27,93B |
| Current Liabilities | 43,29B | 38,75B | 37,84B | 29,54B | 35,19B |